CompletedNCT02520388
Official study titlePh 3 Multicenter DBRCT Parallel Group Study to Evaluate Safety & Efficacy of Evening-dosed HLD200, a Novel Delayed & Extended Release Formulation (DELEXIS) of MPH HCl, on Post-waking, Early Morning Function in Children Aged 6-12 With ADHD
This study has finished and is no longer accepting participants.
Multiple locations, including Newport BeachADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Ironshore Pharmaceuticals and Development, Inc
CompletedACTRN12618000966291
Official study titleA Phase 1, Randomized, Double-Blind, Placebo- and Active-Controlled, Single-Ascending-Dose, 2-Way, Incomplete Block, 2-Period Crossover, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of 3 Doses of INP105 (olanzapine delivered by I231 POD® Device) Nasal Spray in Healthy Volunteers
This study has finished and is no longer accepting participants.
In MelbourneSchizophrenia, BipolarityInterventional studyAges 18–55
- Countries
- Australia
- Sponsor
- Clinical Network Services (CNS) Pty Ltd
CompletedNCT02086864
Official study titleA Randomized, Double Blind, Placebo Controlled Study of Homeopathic Treatment of Children and Youth With Attention Deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In TorontoADHDMedication studyAges 6–16
- Countries
- Canada
- Sponsor
- University of Toronto
TerminatedNCT00591318
Official study titleIV Ceftriaxone for Refractory Psychosis: a Controlled Trial
This study ended early.
In New YorkSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Research Foundation for Mental Hygiene, Inc.
CompletedNCT00455715
Official study titleA Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia
This study has finished and is no longer accepting participants.
In BostonSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT00567814
Official study titleA Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Two Dose Combinations of Metyrapone and Oxazepam in the Treatment of Cocaine Addiction
This study has finished and is no longer accepting participants.
In ShreveportAddictionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Embera NeuroTherapeutics, Inc.
CompletedNCT00302107
Official study titleA Placebo-Controlled Study of Mirtazapine for PTSD in OIF/OEF Veterans
This study has finished and is no longer accepting participants.
In TuscaloosaPTSD, AnxietyMedication studyAges 19–65
- Countries
- United States
- Sponsor
- US Department of Veterans Affairs
CompletedNCT00421603
Official study titleA Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) and Topiramate for the Treatment of Cocaine Dependence
This study has finished and is no longer accepting participants.
In New YorkADHDMedication studyAges 18–60
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
CompletedNCT01091506
Official study titleA Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients
This study has finished and is no longer accepting participants.
In BostonSchizophreniaPlacebo comparisonAges 18–68
- Countries
- United States
- Sponsor
- Pamlab, Inc.
CompletedEUCTR 2004-000955-40
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In LatviaAnxietyHistorical research record
- Countries
- Latvia
- Sponsor
- Pfizer Global Research & Development
CompletedNCT00371176
Official study titleA Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD
This study has finished and is no longer accepting participants.
In BostonPTSDMedication studyAges 18+
- Countries
- United States
- Sponsor
- US Department of Veterans Affairs
CompletedNCT00573417
Official study titleA Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In BostonSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- North Suffolk Mental Health Association
